President and Chief Scientific Officer of Power3 Medical Products, Inc. (PWRM.OB) to Give Plenary Address to the European Molecular Histopathology Symposium
Power3 Medical Products, Inc. and StemTroniX, Inc. announced yesterday that Ira L. Goldknopf, PhD, Power3's President and Chief Scientific Officer, will deliver a plenary address to the European Molecular Histopathology Symposium on The Impact of Personalized Medicine, April 29, 2010, in Chantilly, France. The title of the plenary address is "The Genesis of Prototype Biomarkers for Identification and Use of Stem Cells for Therapeutics of Alzheimer’s Disease." Ventana Medical Systems, a member of the Roche Group, is the organizer of the Symposium. The focus of the presentation is on the progress Power3 Medical Products, Inc. and StemTroniX, Inc. have made…